Cartalax
Also known as: Cartilage peptide bioregulator · AC-4 cartilage complex · Sigumir alternative
A cartilage and bone-targeting peptide bioregulator from the Khavinson series. Studied for arthritis, osteochondrosis, fracture recovery, and joint aging. Stimulates chondrocyte proliferation and collagen synthesis in cartilage tissue, supporting structural repair and maintenance of joint integrity.
What is Cartalax? A cartilage and bone-targeting peptide bioregulator from the Khavinson series. Studied for arthritis, osteochondrosis, fracture recovery, and joint aging. Stimulates chondrocyte proliferation and collagen synthesis in cartilage tissue, supporting structural repair and maintenance of joint integrity.
How does Cartalax work? Cartalax targets chondrocyte and osteoblast nuclei, regulating genes involved in extracellular matrix synthesis, collagen production, and proteoglycan synthesis. It promotes chondrocyte proliferation, inhibits MMP (matrix metalloproteinase) activity that degrades cartilage, and stimulates aggrecan and type-II collagen synthesis — the key components of healthy articular cartilage.
Benefits of Cartalax: Stimulates chondrocyte proliferation; Increases collagen type II and aggrecan synthesis; Inhibits cartilage-degrading MMPs; Fracture and cartilage injury recovery; Anti-aging effects in joints; Osteoarthritis and osteochondrosis research; Synergistic with BPC-157 for joint healing
Cartalax dosage: Standard Khavinson protocol: 1-2mg/day for 10 days, 2x per year. Often combined with BPC-157 for comprehensive joint healing.
Research status: Research Only
Source: PeptideWiki — https://www.peptide-wiki.net/peptides/cartalax
Mechanism of Action
Cartalax targets chondrocyte and osteoblast nuclei, regulating genes involved in extracellular matrix synthesis, collagen production, and proteoglycan synthesis. It promotes chondrocyte proliferation, inhibits MMP (matrix metalloproteinase) activity that degrades cartilage, and stimulates aggrecan and type-II collagen synthesis — the key components of healthy articular cartilage.
Benefits
- Stimulates chondrocyte proliferation
- Increases collagen type II and aggrecan synthesis
- Inhibits cartilage-degrading MMPs
- Fracture and cartilage injury recovery
- Anti-aging effects in joints
- Osteoarthritis and osteochondrosis research
- Synergistic with BPC-157 for joint healing
Side Effects & Risks
- Generally well tolerated
- Injection site reactions
- Limited Western clinical data
Where to Buy Cartalax
1 option across 1 vendor · Sorted cheapest first · All include direct product link
From
$39.99
All links are affiliate links — PeptideWiki earns a commission at no extra cost to you. Coupon codes apply at checkout. Prices and availability may change. Always verify COA before purchasing.
Storage & Reconstitution Guide
Storage Temperature
-20°C (lyophilized)
24 months (lyophilized), 28 days (reconstituted)
Reconstitution Solvent
Bacteriostatic water (BAC water)
Swirl gently — do not shake or vortex
Handling Notes
Protect lyophilized peptide from moisture and light. Once reconstituted, keep refrigerated. Discard if solution becomes cloudy or discolored. Use insulin syringe for precise dosing.
Step-by-Step Reconstitution
Gather supplies
BAC water, insulin syringe, alcohol swabs, vial
Disinfect tops
Swab rubber stoppers of both vials with alcohol
Draw BAC water
Pull desired mL of BAC water into syringe
Inject slowly
Inject BAC water down the side of the peptide vial, swirl gently to dissolve
Research Protocol
- Dose Range
- 1–2 mg
- Frequency
- Daily for 10-day courses
- Cycle
- 10-day courses, 2x per year
- Routes
- subcutaneous injection
- Notes
- Standard Khavinson protocol: 1-2mg/day for 10 days, 2x per year. Often combined with BPC-157 for comprehensive joint healing.
Legal & Regulatory Status
Sold for research purposes only. Not for human use. Laws vary by country.
Commonly Stacked With
View all peptide stacks →External Resources
Chemical Properties
- Mol. Weight
- ~480 Da
PeptideWiki Research Team
Evidence-based research data sourced from PubMed and ClinicalTrials.gov · Last updated: February 25, 2026
Frequently Asked Questions About Cartalax
What is Cartalax?▾
A cartilage and bone-targeting peptide bioregulator from the Khavinson series. Studied for arthritis, osteochondrosis, fracture recovery, and joint aging. Stimulates chondrocyte proliferation and collagen synthesis in cartilage tissue, supporting structural repair and maintenance of joint integrity.
What are the benefits of Cartalax?▾
Stimulates chondrocyte proliferation
What are the benefits of Cartalax?▾
Increases collagen type II and aggrecan synthesis
What are the side effects of Cartalax?▾
Generally well tolerated
What is the recommended dosage for Cartalax?▾
Standard Khavinson protocol: 1-2mg/day for 10 days, 2x per year. Often combined with BPC-157 for comprehensive joint healing.
How long should a Cartalax cycle last?▾
10-day courses, 2x per year
More Healing & Recovery Peptides
View all Healing & Recovery peptides →Cardiogen
Heart peptide bioregulator
A tetrapeptide cardiac bioregulator from the Khavinson series targeting myocardial tissue. Normalizes myocardial cell function, reduces cardiac oxidative stress, and provides cardioprotection against ischemia and aging-related cardiac decline. Studied for heart failure, cardiomyopathy, and post-infarction recovery.
ARA-290
Cibinetide
A synthetic 11-amino acid peptide that mimics the tissue-protective actions of erythropoietin without its erythropoietic effects. Highly effective for neuropathic pain and nerve repair.
Svetinorm
BioLiver
A liver-targeting tetrapeptide bioregulator. Normalizes hepatocyte function, reduces liver fibrosis, improves bile acid metabolism, and protects against hepatotoxicity. Studied for NAFLD, alcohol-related liver damage, hepatitis recovery, and liver aging.
Thymosin Beta-4 Fragment (TB-4 Frag)
TB4 Fragment
A synthetic 4-amino acid fragment (Ac-SDKP) derived from the N-terminus of Thymosin Beta-4. This specific fragment is responsible for many of TB-500's anti-inflammatory, stem cell mobilization, and cardiac healing properties, in a more targeted and stable form.